Correlation Between Moonpig Group and Faron Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moonpig Group and Faron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moonpig Group and Faron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moonpig Group PLC and Faron Pharmaceuticals Oy, you can compare the effects of market volatilities on Moonpig Group and Faron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moonpig Group with a short position of Faron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moonpig Group and Faron Pharmaceuticals.

Diversification Opportunities for Moonpig Group and Faron Pharmaceuticals

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Moonpig and Faron is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Moonpig Group PLC and Faron Pharmaceuticals Oy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Faron Pharmaceuticals and Moonpig Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moonpig Group PLC are associated (or correlated) with Faron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Faron Pharmaceuticals has no effect on the direction of Moonpig Group i.e., Moonpig Group and Faron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Moonpig Group and Faron Pharmaceuticals

Assuming the 90 days trading horizon Moonpig Group PLC is expected to under-perform the Faron Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Moonpig Group PLC is 1.3 times less risky than Faron Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Faron Pharmaceuticals Oy is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  15,250  in Faron Pharmaceuticals Oy on September 24, 2024 and sell it today you would earn a total of  1,250  from holding Faron Pharmaceuticals Oy or generate 8.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Moonpig Group PLC  vs.  Faron Pharmaceuticals Oy

 Performance 
       Timeline  
Moonpig Group PLC 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moonpig Group PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Moonpig Group may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Faron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Moonpig Group and Faron Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moonpig Group and Faron Pharmaceuticals

The main advantage of trading using opposite Moonpig Group and Faron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moonpig Group position performs unexpectedly, Faron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Faron Pharmaceuticals will offset losses from the drop in Faron Pharmaceuticals' long position.
The idea behind Moonpig Group PLC and Faron Pharmaceuticals Oy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal